doi: 10.1016/S2213-8587(24)00059-7.
Epub 2024 Mar 27.
How clinically relevant is statin-induced diabetes?
Affiliations
- PMID: 38554714
- DOI: 10.1016/S2213-8587(24)00059-7
Item in Clipboard
How clinically relevant is statin-induced diabetes?
Lancet Diabetes Endocrinol.
2024 May.
No abstract available
Conflict of interest statement
HCG holds the McMaster-Sanofi Population Health Institute Chair in Diabetes Research and Care. He reports research grants from Eli Lilly, AstraZeneca, Novo Nordisk, Hanmi, and Merck; continuing medical education grants to McMaster University from Eli Lilly, Abbott, Sanofi, Novo Nordisk, and Boehringer Ingelheim; honoraria for speaking from AstraZeneca, Eli Lilly, Novo Nordisk, DKSH, Zuellig, Sanofi, and Jiangsu Hanson; and consulting fees from Abbott, Eli Lilly, Novo Nordisk, Pfizer, Carbon Brand, Sanofi, Kowa, and Hanmi. MP declares no competing interests.
Similar articles
-
Risk of diabetes with statins.BMJ. 2023 May 12;381:e071727. doi: 10.1136/bmj-2022-071727. BMJ. 2023. PMID: 37172967 No abstract available.
-
Strengthening a Study of Diabetes Progression After Statin Use-Reply.JAMA Intern Med. 2022 Apr 1;182(4):460. doi: 10.1001/jamainternmed.2021.8356. JAMA Intern Med. 2022. PMID: 35188526 No abstract available.
-
Risk of new-onset diabetes with high-intensity statin use.Lancet Diabetes Endocrinol. 2024 Sep;12(9):612-613. doi: 10.1016/S2213-8587(24)00217-1. Lancet Diabetes Endocrinol. 2024. PMID: 39174155 No abstract available.
-
Statin-Associated Diabetes Mellitus: Review and Clinical Guide.South Med J. 2016 Mar;109(3):167-73. doi: 10.14423/SMJ.0000000000000423. South Med J. 2016. PMID: 26954655 Review.
-
Statin-associated incident diabetes: a literature review.Consult Pharm. 2014;29(5):317-34. doi: 10.4140/TCP.n.2014.317. Consult Pharm. 2014. PMID: 24849689 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
